HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, Jan. 22, 2018 (HealthDay News) -- In Germany, there was a significant reduction in incidence of blindness from 2008 through 2012, both among individuals with and without diabetes, according to a study published online Jan. 9 in Diabetes Care.
Heiner Claessen, Ph.D., from Heinrich-Heine University in Düsseldorf, Germany, and colleagues used administrative data to identify 1,897 newly registered recipients of blindness allowance from 2008 through 2012. The incidence of blindness was compared in persons with and without diabetes.
The researchers found that 23.7 percent of the new cases of blindness were associated with diabetes. Over the study period there was a strong decrease in incidence in both the population with diabetes (16 percent decrease per year) and among those without diabetes (9 percent decrease per year). Results were similar for both sexes.
"We found a significant reduction in incidence of blindness in the populations with and without diabetes, which was more prominent among individuals with diabetes compared with the 1990s," the authors write. "Our findings may be explained by effective secondary prevention therapies and improved ophthalmologic care beyond diabetic retinopathy, particularly regarding macular degeneration, which means earlier detection and earlier and better treatment."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 28, 2022